DE69012261D1 - Verwendung von Sertralin zur Behandlung verfrühter Ejakulation. - Google Patents

Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.

Info

Publication number
DE69012261D1
DE69012261D1 DE69012261T DE69012261T DE69012261D1 DE 69012261 D1 DE69012261 D1 DE 69012261D1 DE 69012261 T DE69012261 T DE 69012261T DE 69012261 T DE69012261 T DE 69012261T DE 69012261 D1 DE69012261 D1 DE 69012261D1
Authority
DE
Germany
Prior art keywords
sertraline
premature ejaculation
treat premature
ejaculation
treat
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69012261T
Other languages
English (en)
Other versions
DE69012261T2 (de
Inventor
Peter Bick
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23583530&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69012261(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of DE69012261D1 publication Critical patent/DE69012261D1/de
Application granted granted Critical
Publication of DE69012261T2 publication Critical patent/DE69012261T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Reproductive Health (AREA)
  • Endocrinology (AREA)
  • Urology & Nephrology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Steroid Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DE69012261T 1989-08-30 1990-08-17 Verwendung von Sertralin zur Behandlung verfrühter Ejakulation. Expired - Fee Related DE69012261T2 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/400,417 US4940731A (en) 1989-08-30 1989-08-30 Method of treating premature ejaculation using sertraline

Publications (2)

Publication Number Publication Date
DE69012261D1 true DE69012261D1 (de) 1994-10-13
DE69012261T2 DE69012261T2 (de) 1995-01-12

Family

ID=23583530

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69012261T Expired - Fee Related DE69012261T2 (de) 1989-08-30 1990-08-17 Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.

Country Status (19)

Country Link
US (1) US4940731A (de)
EP (1) EP0415613B1 (de)
JP (1) JPH0393718A (de)
KR (1) KR910004187A (de)
AT (1) ATE110958T1 (de)
AU (1) AU609664B1 (de)
CA (1) CA2024188C (de)
CY (1) CY1973A (de)
DE (1) DE69012261T2 (de)
DK (1) DK0415613T3 (de)
HK (1) HK219196A (de)
HU (1) HU213474B (de)
IE (1) IE63470B1 (de)
IL (1) IL95473A (de)
MY (1) MY106938A (de)
NZ (1) NZ235101A (de)
PH (1) PH26998A (de)
PT (1) PT95117B (de)
ZA (1) ZA906883B (de)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0148511B1 (ko) * 1993-09-14 1998-11-02 최형기 성신경과민증 예방 및 치료용 의약조성물
US5597826A (en) 1994-09-14 1997-01-28 Pfizer Inc. Compositions containing sertraline and a 5-HT1D receptor agonist or antagonist
BR9810403A (pt) 1997-07-01 2000-08-29 Pfizer Sais da sertralina e formas de dosagem de liberação sustentada da sertralina
US20040208926A1 (en) * 1997-07-01 2004-10-21 Pfizer Inc Solubilized sertraline compositions
US20030133974A1 (en) * 1997-07-01 2003-07-17 Curatolo William John Encapsulated solution dosage forms of sertraline
US6228864B1 (en) 1997-10-28 2001-05-08 Vivus, Inc. Administration of 5-HT receptor agonists and antagonists, to treat premature ejaculation
US5922341A (en) * 1997-10-28 1999-07-13 Vivus, Incorporated Local administration of pharmacologically active agents to treat premature ejaculation
US6403597B1 (en) 1997-10-28 2002-06-11 Vivus, Inc. Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation
US6037360A (en) * 1997-10-28 2000-03-14 Vivus, Incorporated Administration of 5-HT3 receptor antagonists to treat premature ejaculation
KR100417200B1 (ko) * 1998-10-13 2004-02-05 화이자 프로덕츠 인코포레이티드 세트랄린 경구 농축물
IL132500A0 (en) 1998-10-29 2001-03-19 Pfizer Prod Inc Stereoselective microbial reduction of a racemic tetralone
JP2002538134A (ja) * 1999-03-01 2002-11-12 ファイザー・インク 療法に有用な１，２，３，４−テトラヒドロ−１−ナフタレンアミン化合物
US6245782B1 (en) 1999-05-17 2001-06-12 Heartdrug Research L.L.C. Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
DE122009000036I2 (de) 1999-09-03 2010-05-06 Apbi Holdings Llc Verwendung von Dapoxetin, ein selektiver Serotonin Aufnahme Inhibitor mit schnellem Wirkungseintritt, zur Behandlung von sexueller Dysfunktion
EP1239839A2 (de) 1999-12-23 2002-09-18 Pfizer Products Inc. Durch hydrogel gesteuerte mehrschichtige dosierungsform enthaltend sertralin
US6448293B1 (en) 2000-03-31 2002-09-10 Pfizer Inc. Diphenyl ether compounds useful in therapy
GB0007884D0 (en) * 2000-03-31 2000-05-17 Pfizer Ltd Diphenyl ether compounds useful in therapy
CN1091096C (zh) * 2000-09-15 2002-09-18 哈尔滨健迪医药科技开发有限公司 舍曲林柠檬酸盐及其用于治疗哺乳动物早泄的用途
US6495154B1 (en) 2000-11-21 2002-12-17 Vivus Inc. On demand administration of clomipramine and salts thereof to treat premature ejaculation
CN1289071C (zh) 2001-03-16 2006-12-13 Dmi生物科学公司 曲马朵物质在制备用于延缓男性射精的药物中的用途
US20040131672A1 (en) * 2003-01-07 2004-07-08 Nilobon Podhipleux Direct compression pharmaceutical composition containing a pharmaceutically active ingredient with poor flowing properties
AU2003903597A0 (en) * 2003-07-11 2003-07-24 Jakov Vaisman Treatment of premature ejaculation
WO2005102366A2 (en) * 2004-04-19 2005-11-03 Philip Maxwell Satow Lithium combinations, and uses related thereto
WO2005117911A2 (en) * 2004-05-06 2005-12-15 Cydex, Inc. Taste-masked formulations containing sertraline and sulfoalkyl ether cyclodextrin
US8604082B2 (en) * 2005-12-13 2013-12-10 Trinity Laboratories, Inc. Method to treat premature ejaculation in humans
US7893053B2 (en) 2006-06-16 2011-02-22 Theracos, Inc. Treating psychological conditions using muscarinic receptor M1 antagonists
US20090005319A1 (en) * 2007-07-01 2009-01-01 Barone Jr Frank V Topical compositions for delaying ejaculation and methods of using the same
US9272671B2 (en) 2013-06-28 2016-03-01 Faurecia Interior Systems, Inc. Display screen arrangement and method of assembly

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4029731A (en) * 1974-11-06 1977-06-14 Pfizer Inc. Aminophenyltetralin compounds
US4536518A (en) * 1979-11-01 1985-08-20 Pfizer Inc. Antidepressant derivatives of cis-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
US4507323A (en) * 1984-07-25 1985-03-26 Burroughs Wellcome Co. Treatment of psychosexual dysfunctions
US4962128A (en) * 1989-11-02 1990-10-09 Pfizer Inc. Method of treating anxiety-related disorders using sertraline

Also Published As

Publication number Publication date
EP0415613A2 (de) 1991-03-06
MY106938A (en) 1995-08-30
PT95117B (pt) 1997-05-28
KR910004187A (ko) 1991-03-28
ZA906883B (en) 1992-04-29
HU213474B (en) 1997-06-30
IE63470B1 (en) 1995-04-19
HU905682D0 (en) 1991-03-28
IE903123A1 (en) 1991-03-13
AU609664B1 (en) 1991-05-02
IL95473A (en) 1995-08-31
NZ235101A (en) 1997-01-29
JPH0393718A (ja) 1991-04-18
CA2024188A1 (en) 1991-03-01
HUT58512A (en) 1992-03-30
DE69012261T2 (de) 1995-01-12
HK219196A (en) 1997-01-03
US4940731A (en) 1990-07-10
ATE110958T1 (de) 1994-09-15
EP0415613A3 (en) 1992-02-26
CY1973A (en) 1997-09-05
EP0415613B1 (de) 1994-09-07
PT95117A (pt) 1991-05-22
CA2024188C (en) 1994-11-08
PH26998A (en) 1993-02-01
DK0415613T3 (da) 1994-10-10

Similar Documents

Publication Publication Date Title
DE69012261D1 (de) Verwendung von Sertralin zur Behandlung verfrühter Ejakulation.
MY106075A (en) A method of treating anxiety-related disorders using sertraline.
DE69434431D1 (de) Methoden zur behandlung von muskelerkrankungen und muskelstörungen
DE69616376T2 (de) Verwendung von Tiagabin zur Behandlung von Schlafstörungen
ATE144420T1 (de) Verwendung von riluzol zur behandlung von parkinson und den parkinson-syndromen
ATE137965T1 (de) Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
ATE235237T1 (de) Sertralin zur behandlung von post-myocard-infarkt-patienten
ATE96999T1 (de) Verwendung von sertralin zur behandlung von abhaengigkeiten von chemischen stoffen.
DE69428797D1 (de) Verwendung von benzydamin zur behandlung von krankheitszuständen, die durch tnf verursacht werden
MX9602793A (es) Uso de sertralina para tratar pacientes despues de un infarto de miocardio.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee